The mission of the NTRT is to:
- Promote NIDA nicotine/tobacco research interests, primarily across the Institute and NIH
- Serve as a clearinghouse of information to NIDA staff on timely information related to nicotine and tobacco research (including Tobacco Regulatory Science)
- Inform the substance use research community on NIDA activities relating to nicotine and tobacco
- Assist NIDA management in evaluating the nicotine and tobacco research portfolio
- Identify and support new research programs and directions as they relate to nicotine and tobacco.
Goals of the NTRT include:
- Invite speakers to present at NIDA in a virtual format. Topics would rotate across all areas of research supported by NIDA, including basic neuroscience, behavior, clinical research, therapeutic development, epidemiology, and prevention.
- Provide networking opportunities between NIDA program staff and the nicotine and tobacco research staff of NIH IC’s and other HHS organizations (e.g., NCI, NHLBI, NIAAA, NICHD, FDA, and SAMHSA).
- Meet regularly with NIDA Leadership to discuss the NIDA nicotine & tobacco portfolio, any ongoing issues, and identify gap areas to further explore.
- Plan and conduct Pre-Conference Workshops and/or Symposia Sessions at the SRNT Annual Meeting or other scientifically pertinent meetings, possibly in collaboration with other NIH ICs and/or FDA CTP staff.
- Write and distribute the monthly NTRT Newsletter via Listserv email, which includes recent nicotine, tobacco, and tobacco regulatory science focused information. Content areas include high-profile research publications, changes in tobacco regulation, seminars, meetings, funding opportunities, news from the popular press, and related items.
Membership in the NTRT is open to all NIDA extramural and intramural staff. Currently, membership in NTRT includes staff from across the various Divisions, Offices and Centers at NIDA HQ and NIDA IRP. If you would like to join and/or receive the Nicotine & Tobacco Research Team (NTRT) NEWSLETTER, please contact Flair Lindsey, email@example.com.
For questions about the Nicotine and Tobacco Research Team, please contact either of the co-chairs, Mary Kautz, firstname.lastname@example.org, or Heather Kimmel, email@example.com.
The Core Group of NTRT Program Staff have much of the nicotine and tobacco portfolio within each of their divisions or have significant other tobacco-related roles at NIDA. They represent a cross section of expertise such as pre-clinical, clinical, drug development, behavior, services, treatment, and epidemiology.
Investigators interested in applying for NIDA research grants pertaining to nicotine and tobacco are encouraged to contact the relevant Program Staff to discuss their proposal in relation to NIDA research priorities. Additionally, investigators can review the NIDA strategic plan, which discusses the Institute's research priorities.
|Name||Program Staff Title||Branch||Division||Areas of Expertise|
|Program Officer||Clinical Research Grants Branch||Division of Therapeutics and Medical Consequence|
|Training Coordinator||Office of the DNB Director||Division of Neuroscience and Behavior|
|Deputy Director||Office of the Director||Office of the Director|
|Health Scientist Administrator||Epidemiology Research Branch||Division of Epidemiology, Services and Prevention Research|
|Program Officer||Behavioral and Cognitive Neuroscience Branch||Division of Neuroscience and Behavior|
|Medical Officer||Services Research Branch||Division of Epidemiology, Services and Prevention Research|
|Health Scientist Administrator||Clinical Research Grants Branch||Division of Therapeutics and Medical Consequences|
Director, NIDA Tobacco Regulatory Science
|Behavioral and Cognitive Neuroscience Branch||Division of Neuroscience and Behavior|
The PATH Study Director at NIH
|Epidemiology Research Branch||Division of Epidemiology, Services and Prevention Research|
Director, NIDA Drug Supply Program
|Chemistry and Pharmaceutics Branch||Division of Therapeutics and Medical Consequences|
|Program Analyst||Behavioral and Cognitive Neuroscience Branch||Division of Neuroscience and Behavior|
|Scientific Program Manager||Behavioral and Cognitive Neuroscience Branch||Division of Neuroscience and Behavior|
|Branch Chief||Genetics, Epigenetics, and Developmental Neuroscience Branch||Division of Neuroscience and Behavior|
|Program Officer||Prevention Research Branch||Division of Epidemiology, Services and Prevention Research|
|Program Officer||Integrative Neuroscience Branch||Division of Neuroscience and Behavior|
No Photo Available
|Program Officer||Chemistry and Pharmacology Branch||Division of Neuroscience and Behavior|
Tobacco Regulatory Science Program (TRSP) Notice of Funding Opportunities (NOFOs)
- The Tobacco Regulatory Science (R01 Clinical Trial Optional) - RFA-OD-23-017
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 Independent Clinical Trial Not Allowed) - RFA-OD-22-023
- Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 Independent Clinical Trial Required) - RFA-OD-22-024
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 Independent Clinical Trial Not Allowed) - RFA-OD-22-025
- Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 Independent Clinical Trial Required) - RFA-OD-22-026
- Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01 Clinical Trial Required) - RFA-OD-23-021
Other NOFOs and Notices
- Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects - Notice of Special Interest - NOT-OD-22-023
- Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes - Notice of Special Interest -NOT-AA-21-028
- Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) - PAR-24-027
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional) - PA-21-180 (R34)
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) - PAR-19-368
- Advancing Adolescent Tobacco Cessation Intervention Research (R01 Clinical Trial Required) - RFA-CA-22-043
- Advancing Adolescent Tobacco Cessation Intervention Research (R34 Clinical Trial Optional) - RFA-CA-22-042
For a listing of the most up to date NOFOs, please visit NIH TRSP site.